Healthcare
Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb stock analysis and opportunity scoring
$66.58
↓ -0.55%
Bristol-Myers Squibb (BMY) at a glance
Bristol-Myers Squibb (BMY) is a publicly traded company in the Healthcare - Drug Manufacturers - General sector tracked by MKD Intelligence.
BMY last traded at $62.09 as of 2026-08-28.
MKD Intelligence assigns BMY a composite opportunity score of 65 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for BMY is 39 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$67.92
Low
$62.09
Period
Aug 28 - Jul 24 (26d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Aug 28
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.